Clostridium Difficile News and Research

RSS
Clostridium difficile is a type of bacterium found in human and animal waste. Clostridium difficile is a common cause of diarrhea that occurs in hospitals. It can also cause diarrhea or other intestinal disorders in patients treated with antibiotics.
UGA researcher works to advance effective treatment for infectious mononucleosis

UGA researcher works to advance effective treatment for infectious mononucleosis

Existing non-antibiotic therapeutic drugs could help combat antibiotic-resistant pathogens

Existing non-antibiotic therapeutic drugs could help combat antibiotic-resistant pathogens

UC San Diego receives NIH grant to establish interdisciplinary center to combat antibiotic resistance

UC San Diego receives NIH grant to establish interdisciplinary center to combat antibiotic resistance

Novel antibiotics to overcome antibacterial resistance

Novel antibiotics to overcome antibacterial resistance

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Changing one atom in InsP6 inhibitor can increase its ability to neutralize toxins in the gut

Changing one atom in InsP6 inhibitor can increase its ability to neutralize toxins in the gut

Valley Hospital, Holy Name Medical Center collaborate to defeat C. difficile

Valley Hospital, Holy Name Medical Center collaborate to defeat C. difficile

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Discovery takes researchers one step closer to preventing C. diff

Discovery takes researchers one step closer to preventing C. diff

CosmosID announces $6M in Series B funding round

CosmosID announces $6M in Series B funding round

FDA approves Allergan's sNDA to update label for DALVANCE (dalbavancin) for injection

FDA approves Allergan's sNDA to update label for DALVANCE (dalbavancin) for injection

Mayo Clinic adds robots to prevent C-diff bacteria

Mayo Clinic adds robots to prevent C-diff bacteria

Frozen fecal transplantation effective at providing relief to C. diff patients

Frozen fecal transplantation effective at providing relief to C. diff patients

Researcher seeks to identify probiotic mixes to treat Clostridium difficile infections

Researcher seeks to identify probiotic mixes to treat Clostridium difficile infections

Discoveries could lead to development of novel therapies to prevent C. diff infection

Discoveries could lead to development of novel therapies to prevent C. diff infection

Common antibiotics can promote C. diff infections by killing off bile acid-altering microbes

Common antibiotics can promote C. diff infections by killing off bile acid-altering microbes

Candidiasis needs to be treated early, aggressively to help vulnerable hospitalized patients

Candidiasis needs to be treated early, aggressively to help vulnerable hospitalized patients

Bacteriophage therapy: an alternative to antibiotics? An interview Professor Clokie

Bacteriophage therapy: an alternative to antibiotics? An interview Professor Clokie

Loyola professor receives prestigious 2015 Marion Spencer Fay Award

Loyola professor receives prestigious 2015 Marion Spencer Fay Award

Rebiotix's RBX2660 receives FDA Breakthrough Therapy designation for treatment of recurrent C diff infection

Rebiotix's RBX2660 receives FDA Breakthrough Therapy designation for treatment of recurrent C diff infection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.